GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
Articles
GLTO Stock Earnings: Galecto Beats EPS for Q2 2024
GLTO stock results show that Galecto beat analyst estimates for earnings per share the second quarter of 2024. More
FLGC Stock Earnings: Flora Growth Misses EPS, Misses Revenue for Q2 2024
FLGC stock results show that Flora Growth missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024
CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024. More
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024
DYN stock results show that Dyne Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
MOBQ Stock Earnings: Mobiquity Technologies Reported Results for Q2 2024
Mobiquity Technologies just reported results for the second quarter of 2024. More
